Smith & Nephew (SNN) Financial Analysis & Valuation | Quarter Chart
Smith & Nephew (SNN)
SNNPrice: $30.28
Fair Value: 🔒
🔒score
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include ... more
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells m... more
Description
Shares
| Market Cap | $12.83B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | GB | CEO | Deepak S Nath |
| IPO Date | 1999-11-16 | CAGR | 0.06% |
| Employees | 17,818 | Website | www.smith-nephew.com |
| Div. Yield | 2.58% | Payout Ratio | 0.53% |
| Buy Back Yield | 3.93% | Total Yield | 6.51% |
SNN chart loading...
Fundamentals
Technicals
| Enterprise Value | $16.81B | P/E Ratio | 16.35 |
| Forward P/E | 14.03 | PEG Ratio | 0.3 |
| P/S Ratio | 2.04 | P/B Ratio | 2.48 |
| P/CF Ratio | 10.25 | P/FCF Ratio | 15.19 |
| EPS | $1.85 | EPS Growth 1Y | 116.22% |
| EPS Growth 3Y | -17.81% | EPS Growth 5Y | 18.81% |
| Revenue Growth 1Y | 11.37% | Gross Margin | 0.68% |
| Operating Margin | 0.16% | Profit Margin | 0.1% |
| ROE | 0.12% | ROA | 0.06% |
| ROCE | 0.12% | Current Ratio | 2.57 |
| Quick Ratio | 1.25 | Cash Ratio | 0.35 |
| Debt/Equity | 0.63 | Interest Coverage | 6.43 |
| Altman Z Score | 4.16 | Piotroski Score | 7 |